Molecular Epidemiology of Respiratory Syncytial Virus and Rhinovirus in Santander, Colombia, During the COVID-19 Pandemic and Post-Pandemic Periods, 2020–2024

Respiratory syncytial virus (RSV) and rhinovirus (RV) are major causes of acute respiratory infections (ARIs) worldwide. The circulation of both RSV and RV was notably altered during the COVID-19 pandemic. This study analyzed the epidemiological and molecular characteristics of RSV and RV in Santander, Colombia, during the pandemic period (PP, 2020–2021) and the post-pandemic period (PPP, 2023–2024). A total of 921 respiratory samples from patients with ARIs were screened for RSV-A/B and RV. Sequences of the RSV attachment glycoprotein (G) gene and the RV VP4–VP2 region were analyzed in positive samples. Epidemiological and clinical characteristics of the study population were also assessed. RSV was not detected during PP, whereas RV was detected in 4.8% of samples. During PPP, RSV-A, RSV-B, and RV were detected in 5.6%, 4.4%, and 28.0% of samples, respectively. RSV infections were mainly identified in children, while RV was detected across all age groups. RSV-A sequences grouped within seven A.D-derived lineages (A.D.1.5, A.D.1.7, A.D.1.8, A.D.3.2, A.D.3.3, A.D.5.1, A.D.5.2), whereas RSV-B sequences clustered within the B.D.E.1 lineage. RV showed a higher number of detected genotypes during the PPP than during the PP. The genotypic characterization performed in this study provides new insight into the molecular epidemiology of RSV and RV in Santander, Colombia, during PP and PPP, and represents, to our knowledge, the first regional description of RSV lineages and RV genotypes across these periods.